OÜ FAIRFIELD GLOBAL
- Registry code
- 11690172
- VAT number
- EE101426282
- Address
- Harju maakond, Tallinn, Lasnamäe linnaosa, Mahtra tn 30a, 13811
- Registered
- 14.07.2009 · 17 yrs
- Activity
- Wholesale of pharmaceutical goods 46462
- Capital
- 2 556 €
- f•••@g•••.comLog in to see
- Phone
- +372 •• ••••Log in to see
- No tax debt
- No enforcement proceedings (12 months)
- No payment orders (12 months)
- No bankruptcy or liquidation
- No sanctions
- Report filed (2025)
- VAT registered
Add the rating badge to your website
The badge code is available to this company's verified account: verification uses a code we send to the company email in the Business Register. The badge updates itself and cannot be bought. Read more
Board and owners
1 persons
| Board 1 | ||
|---|---|---|
| Yana Budziakova2 companiesno tax debt | Personal ID ↗ | 21.03.2019 |
| Shareholders 1 | ||
| MedS&P AS | 100,0% 2 556 € | 01.04.2026 |
| Beneficial owners 1 | ||
| Dmitri Krõlenkov1 companyno tax debtkaudne osalus | 26.03.2026 | |
Business Register open data
Quarterly taxes and revenue
2026 Q2
2026 Q2. Wage is estimated from employment taxes.
| Quarter | Revenue | Change y/y | Labour taxes | State taxes | Employees |
|---|---|---|---|---|---|
| 2026 Q2 | 18 223 € | ▲ 113% | 10 606 € | 10 197 € | 1 |
| 2026 Q1 | 46 724 € | ▼ 12% | 15 376 € | 14 565 € | 2 |
| 2025 Q4 | 120 251 € | ▲ 388% | 17 640 € | 16 671 € | 3 |
| 2025 Q3 | 8 644 € | ▼ 91% | 18 391 € | 17 568 € | 3 |
| 2025 Q2 | 8 544 € | ▼ 94% | 17 640 € | 16 671 € | 3 |
| 2025 Q1 | 53 284 € | ▼ 84% | 18 235 € | 17 254 € | 3 |
| 2024 Q4 | 24 635 € | ▼ 88% | 18 282 € | 17 347 € | 3 |
| 2024 Q3 | 100 129 € | ▼ 93% | 19 479 € | 18 338 € | 4 |
| 2024 Q2 | 140 095 € | ▼ 84% | 18 343 € | 17 243 € | 4 |
| 2024 Q1 | 330 360 € | ▲ 10% | 18 343 € | 17 243 € | 4 |
| 2023 Q4 | 208 691 € | ▼ 55% | 18 343 € | 17 243 € | 4 |
| 2023 Q3 | 1 431 612 € | ▲ 164% | 19 534 € | 18 341 € | 4 |
Show full history (18 quarters)
| 2023 Q2 | 896 834 € | ▲ 513% | 20 471 € | 19 278 € | 4 |
| 2023 Q1 | 299 981 € | ▼ 87% | 20 657 € | 19 456 € | 5 |
| 2022 Q4 | 460 620 € | 21 082 € | 22 572 € | 5 | |
| 2022 Q3 | 541 839 € | 24 399 € | 23 039 € | 5 | |
| 2022 Q2 | 146 384 € | 22 566 € | 21 352 € | 5 | |
| 2022 Q1 | 2 386 997 € | 25 761 € | 24 305 € | 6 |
Tax and Customs Board, published on the 10th of the month following the quarter. State taxes include employment taxes. CC BY-SA 3.0
Annual reports
5 yr
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Sales revenue | 139 k € | ▼ 59% | 339 k € | ▼ 81% | 1,8 m € | ▼ 1% | 1,8 m € | ▲ 56% | 1,1 m € |
| Profit | -178 k € | ▼ 31% | -135 k € | ▼ 100% | -67 709 € | ▼ 2% | -66 598 € | ▲ 85% | -432 k € |
| Profit margin | -127,6% | -39,9% | -3,8% | -3,7% | -38,0% | ||||
| Retained earnings | 1,0 m € | ▼ 12% | 1,1 m € | ▼ 6% | 1,2 m € | ▼ 5% | 1,3 m € | ▼ 25% | 1,7 m € |
| Cash | 114 k € | ▼ 56% | 259 k € | ▼ 53% | 557 k € | ▼ 25% | 742 k € | ▼ 29% | 1,0 m € |
| Current assets | 851 k € | ▼ 17% | 1,0 m € | ▼ 12% | 1,2 m € | ▼ 6% | 1,2 m € | ▼ 10% | 1,4 m € |
| Fixed assets | 0 € | 0 € | 0 € | 0 € | ▼ 100% | 8 907 € | |||
| Assets | 851 k € | ▼ 17% | 1,0 m € | ▼ 12% | 1,2 m € | ▼ 6% | 1,2 m € | ▼ 11% | 1,4 m € |
| Current liabilities | 19 255 € | 0% | 19 248 € | ▼ 3% | 19 872 € | ▼ 27% | 27 248 € | ▼ 75% | 110 k € |
| Total liabilities | 19 255 € | 0% | 19 248 € | ▼ 3% | 19 872 € | ▼ 27% | 27 248 € | ▼ 75% | 110 k € |
| Equity | 832 k € | ▼ 18% | 1,0 m € | ▼ 12% | 1,1 m € | ▼ 6% | 1,2 m € | ▼ 5% | 1,3 m € |
| Labour costs | 166 k € | ▼ 7% | 179 k € | ▼ 13% | 206 k € | ▼ 18% | 252 k € | ▼ 7% | 272 k € |
| Employees | 3 | ▼ 25% | 4 | ▼ 20% | 5 | ▼ 38% | 8 | 0% | 8 |
| Filed | 16.04.2026 | 05.06.2025 | 11.06.2024 | 07.06.2023 | 29.06.2022 | ||||
| Report | PDF ↓ | PDF ↓ | PDF ↓ | PDF ↓ | PDF ↓ |
▲ growth, ▼ decline compared to the previous year (growth in liabilities is red). Business Register, annual reports. CC BY 4.0
Revenue by activity
2025
| Activity | EMTAK | Sales revenue | Osa |
|---|---|---|---|
| Wholesale of pharmaceutical goods main activity | 46462 | 139 184 € | 100% |
2025 annual report, RIK open data
Real estate
e-kinnistusraamat
Loading properties…
Source: e-kinnistusraamat (Centre of Registers and Information Systems), basic data
Debts and court cases
clean
Tax Board debtor list (daily), Official Announcements, State Gazette. The Tax Board publishes only today's list; earlier history is collected by Firmo.
Enforcement, payment orders and notices
clean
Official Announcements contain no enforcement, payment order or tax authority notices about the company.
Official Announcements (CC BY-SA 4.0). Enforcement proceedings, payment orders or tax decisions are published there only if they cannot be delivered to the company otherwise. The enforcement register is not public, so the absence of a notice does not mean there are no claims.
State: transactions, tenders, grants
none
No transactions with state agencies, procurement contracts or grants found
RTK Saldo, Riigihangete register, RTK toetatud projektid
Holdings in other companies
0
No holdings in other companies
Companies linked via the board
1
Sorted by revenue (latest report or 4 quarters).
Top 20 in activity: Wholesale of pharmaceutical goods
20
| # | Company | Revenue |
|---|---|---|
| 1 | OSAÜHING MN MEDICAL | 21,0 m € |
| 2 | aktsiaselts SEMETRON | 20,0 m € |
| 3 | Mediq Eesti OÜ | 17,8 m € |
| 4 | Trimix Point AS | 16,8 m € |
| 5 | Linus Medical OÜ | 14,9 m € |
| 6 | OSAÜHING HANSA MEDICAL | 14,5 m € |
| 7 | Siemens Healthcare Oy Eesti filiaal | 13,7 m € |
| 8 | AB Medical Group Eesti osaühing | 13,3 m € |
| 9 | OneMed OÜ | 13,1 m € |
| 10 | Osaühing B.Braun Medical | 12,6 m € |
| 11 | Quantum Eesti AS | 10,9 m € |
| 12 | Johnson & Johnson AB Eesti filiaal | 10,8 m € |
| 13 | AKTSIASELTS MEDITSIINIGRUPP | 10,6 m € |
| 14 | Olympus Estonia OÜ | 8,0 m € |
| 15 | Abbott Medical Estonia OÜ | 6,5 m € |
| 16 | LTMed OÜ | 6,4 m € |
| 17 | IDTG OÜ | 6,4 m € |
| 18 | UAB MedUS Medical Eesti filiaal | 5,2 m € |
| 19 | Elaine Medical OÜ | 4,8 m € |
| 20 | ISIS Medical OÜ | 4,6 m € |
Revenue from the latest annual report, otherwise Tax Board revenue for 4 quarters. All companies in this activity
Licences, pledges, domains
No data
History and notices
21
| Date | Type | Content |
|---|---|---|
| 01.04.2026 | Entry | Amendment entry |
| 14.03.2025 | Entry | Amendment entry |
| 02.09.2023 | Entry | Amendment entry |
| 08.07.2022 | Administrative order | |
| 08.02.2022 | Entry | Amendment entry |
| 31.01.2022 | Order to remedy deficiencies | Amendment entry |
| 21.09.2020 | Entry | Amendment entry |
| 21.03.2019 | Entry | Amendment entry |
| 12.03.2019 | Negative entry order: deficiencies not remedied | Amendment entry |
| 19.02.2019 | Order to remedy deficiencies | Amendment entry |
| 17.01.2018 | Entry | Amendment entry |
| 05.01.2018 | Entry | Amendment entry |
| 01.12.2017 | Entry | Amendment entry |
| 19.06.2017 | Entry | Amendment entry |
| 14.09.2016 | Entry | Amendment entry |
| 08.05.2014 | Entry | Amendment entry |
| 29.04.2011 | Entry | Amendment entry |
| 24.01.2011 | Entry | Amendment entry |
| 19.11.2010 | Entry | Amendment entry |
| 11.05.2010 | Entry | Amendment entry |
| 14.07.2009 | Entry | First entry |